years was 90.3% (n[90) and 66.9% (n[69). The median SFS was 27.9 months. CSS at 1 and 3 years was 92.2% and 43.7%, respectively. 78.6% of the patients were symptom-free during their remaining lifetime.CONCLUSIONS: Multivisceral radical pelvic surgery is a technically feasible approach in well-selected patients resulting in symptom relief of > 90% of patients which covered almost 80% of the remaining life time. Palliative surgery needs to be considered more frequently iin the therapeutic armentarium of locally symptomatic CRPC. Adequate preoperative imaging studies, endoscopic evaluation and extensive surgical experience is mandatory to achieving a benefit for the individual patient with improvement of quality of life.